kabutan

TOWA PHARMACEUTICAL CO.,LTD.(4553) Summary

4553
TSE Prime
TOWA PHARMACEUTICAL CO.,LTD.
4,330
JPY
+140
(+3.34%)
Feb 19, 3:30 pm JST
27.92
USD
Feb 19, 1:30 am EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
12.0
PBR
1.12
Yield
1.85%
Margin Trading Ratio
4.96
Stock Price
Feb 19, 2026
Opening Feb 19, 9:00 am
4,145 JPY 26.79 USD
Previous Close Feb 18
4,190 JPY 27.30 USD
High Feb 19, 10:49 am
4,350 JPY 28.07 USD
Low Feb 19, 9:00 am
4,140 JPY 26.76 USD
Volume
180,600
Trading Value
0.78B JPY 5.00M USD
VWAP
4298.27 JPY 27.71 USD
Minimum Trading Value
433,000 JPY 2,792 USD
Market Cap
0.22T JPY 1.44B USD
Number of Trades
521
Liquidity & Number of Trades
As of Feb 19, 2026
Liquidity
Slightly High
1-Year Average
489
1-Year High May 16, 2025
2,469
Margin Trading
Date Short Interest Long Margin Positions Ratio
Feb 13, 2026 60,700 39,400 0.65
Feb 6, 2026 52,500 37,000 0.70
Jan 30, 2026 49,100 38,500 0.78
Jan 23, 2026 49,000 50,700 1.03
Jan 16, 2026 47,600 41,700 0.88
Company Profile
TOWA PHARMACEUTICAL CO.,LTD. is a leading generic drug manufacturer with strengths in cardiovascular products. The company has expanded from serving clinics to pharmacies and has also entered the healthcare business.
Sector
Pharmaceuticals
TOWA PHARMACEUTICAL CO.,LTD. specializes in the manufacture and sale of prescription drugs, ranking among the top domestic producers of generic medicines, its main product line. The company directly sells its self-manufactured pharmaceuticals to medical institutions, as well as to distributors, pharmaceutical wholesalers, and other manufacturers. Through its group companies, TOWA is also involved in active pharmaceutical ingredient research and production, soft capsule manufacturing, and the planning, development, and contract manufacturing of health foods. Internationally, the company operates generic drug businesses in Europe and the United States through its holding company. Its group companies have research, development, and manufacturing bases in Europe, where they conduct generic drug sales and contract research, development, and manufacturing services.